Thomas Kerkhofs

1.6k total citations
20 papers, 637 citations indexed

About

Thomas Kerkhofs is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Thomas Kerkhofs has authored 20 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Cancer Research. Recurrent topics in Thomas Kerkhofs's work include Adrenal and Paraganglionic Tumors (17 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Pituitary Gland Disorders and Treatments (9 papers). Thomas Kerkhofs is often cited by papers focused on Adrenal and Paraganglionic Tumors (17 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Pituitary Gland Disorders and Treatments (9 papers). Thomas Kerkhofs collaborates with scholars based in Netherlands, United States and Italy. Thomas Kerkhofs's co-authors include Harm R. Haak, Rob H.A. Verhoeven, Lonneke V. van de Poll‐Franse, Thera P. Links, Jeanne P. Dieleman, Jan Maarten van der Zwan, Michiel N. Kerstens, Tineke P. Willems, Ido P. Kema and M. N. Kerstens and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, European Journal of Cancer and Clinical Pharmacokinetics.

In The Last Decade

Thomas Kerkhofs

18 papers receiving 633 citations

Peers

Thomas Kerkhofs

SURGE

EDM

GENET

Barbara Zaggia Italy

Arianna Ardito Italy

Maria Candida Barisson Villares Fragoso Brazil

G. Abiven France

Alfredo Berruti Italy

Felix Megerle Germany

Christopher P. Bambach Australia

Staffan Gröndal Sweden

Anouk van Berkel Netherlands

David Taïeb France

Barbara Zaggia Italy

Thomas Kerkhofs

864 ×1.6

SURGE

666 ×1.6

588 ×1.6

EDM

229 ×1.4

GENET

45 ×1.0

Citations per year, relative to Thomas Kerkhofs Thomas Kerkhofs (= 1×) peers Barbara Zaggia

Countries citing papers authored by Thomas Kerkhofs

Since Specialization

Citations

This map shows the geographic impact of Thomas Kerkhofs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kerkhofs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kerkhofs more than expected).

Fields of papers citing papers by Thomas Kerkhofs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kerkhofs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kerkhofs. The network helps show where Thomas Kerkhofs may publish in the future.

Co-authorship network of co-authors of Thomas Kerkhofs

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kerkhofs. A scholar is included among the top collaborators of Thomas Kerkhofs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kerkhofs. Thomas Kerkhofs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kelly, John J., Iryna Samarska, Bram Ramaekers, et al.. (2025). Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers. BMC Cancer. 25(1). 1672–1672.

Joosten, Sophie C., Maureen J.B. Aarts, Thomas Kerkhofs, et al.. (2024). A Systematic Review on Prognostic DNA Methylation Markers for Renal Cell Carcinoma: Are We Moving Forward?. JU Open Plus. 2(4).

Zwan, Jan Maarten van der, Stefan A.W. Bouwense, M. Wouter Dercksen, et al.. (2022). Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study. European Journal of Cancer. 172. 252–263. 16 indexed citations

Kerkhofs, Thomas, Floortje Mols, Michiel N. Kerstens, et al.. (2022). Health-Related Quality of Life in Adrenocortical Carcinoma: Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry. Cancers. 14(6). 1366–1366. 4 indexed citations

Swen, Jesse J., Thomas Kerkhofs, Eleonora P.M. Corssmit, et al.. (2020). Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing. Clinical Pharmacokinetics. 60(1). 89–102. 7 indexed citations

Kerkhofs, Thomas, et al.. (2020). Past, Present and Future of Epigenetics in Adrenocortical Carcinoma. Cancers. 12(5). 1218–1218. 22 indexed citations

Kerkhofs, Thomas, et al.. (2015). Developing treatment for adrenocortical carcinoma. Endocrine Related Cancer. 22(6). R325–R338. 30 indexed citations

Kerkhofs, Thomas, M. N. Kerstens, Ido P. Kema, Tineke P. Willems, & Harm R. Haak. (2015). Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors. Hormones and Cancer. 6(4). 168–175. 76 indexed citations

Kerkhofs, Thomas, et al.. (2015). Adrenal Tumors with Unexpected Outcome: A Review of the Literature. International Journal of Endocrinology. 2015. 1–7. 17 indexed citations

10.

Kerkhofs, Thomas, Rob H.A. Verhoeven, Gertjan J.L. Kaspers, et al.. (2014). Adrenocortical carcinoma in children: First population-based clinicopathological study with long-term follow-up. Oncology Reports. 32(6). 2836–2844. 34 indexed citations

11.

Kerkhofs, Thomas, Luc J. J. Derijks, Jan den Hartigh, et al.. (2014). Development of a Pharmacokinetic Model of Mitotane. Therapeutic Drug Monitoring. 37(1). 58–65. 17 indexed citations

12.

Kerkhofs, Thomas, Luc J. J. Derijks, Elisabeth M. W. Eekhoff, et al.. (2014). Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring. European Journal of Endocrinology. 171(6). 677–683. 9 indexed citations

13.

Kerkhofs, Thomas, Éric Baudin, Massimo Terzolo, et al.. (2013). Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 98(12). 4759–4767. 67 indexed citations

14.

Kerkhofs, Thomas, Rob H.A. Verhoeven, H. J. Bonjer, et al.. (2013). Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data. European Journal of Endocrinology. 169(1). 83–89. 48 indexed citations

15.

Kerkhofs, Thomas, Rob H.A. Verhoeven, Jan Maarten van der Zwan, et al.. (2013). Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993. European Journal of Cancer. 49(11). 2579–2586. 232 indexed citations

16.

Hermsen, I G C, Harm R. Haak, Ronald R. de Krijger, et al.. (2013). Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinoma. European Journal of Endocrinology. 169(1). 51–58. 14 indexed citations

17.

Kerkhofs, Thomas, Éric Baudin, Massimo Terzolo, et al.. (2013). Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma. Endocrine Abstracts. 3 indexed citations

18.

Kerkhofs, Thomas, Rob H.A. Verhoeven, Jeanne P. Dieleman, et al.. (2013). Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Endocrine Abstracts. 4 indexed citations

19.

Hermsen, I G C, Thomas Kerkhofs, J. Kievit, et al.. (2012). Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery. Surgery. 152(1). 50–56. 36 indexed citations

20.

Hermsen, I G C, et al.. (2011). Surgery in adrenocortical carcinoma; importance of national cooperation and centralized surgery. Data Archiving and Networked Services (DANS). 26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact